ArticleEye (London, England)2025

Cost-effectiveness of anti-vascular endothelial growth factor and macular laser treatments for people with centre-involving diabetic macular oedema and central retinal thickness of at least 400 micrometres.

Kirsty Luckham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.